The coumarin antibiotic coumermycin A 1 contains at least eight methyl groups, presumably derived from S-adenosylmethionine. Two putative methyltransferase genes, couO and couP, of the coumermycin A 1 biosynthetic gene cluster were inactivated by in-frame deletion. In the resulting mutants, coumermycin A 1 production was abolished. New coumermycin derivatives were accumulated instead, and were identified by HPLC-MS using selected reaction monitoring via electrospray ionization. couO mutants accumulated a coumermycin derivative lacking the methyl groups at C-8 of the characteristic aminocoumarin rings, whereas in the couP mutant a coumermycin derivative lacking the methyl groups at the 4-hydroxyl groups of the two deoxysugar moieties was identified. These results provided evidence that couO encodes a C-methyltransferase responsible for the transfer of a methyl group to C-8 of the aminocoumarin ring, and couP an O-methyltransferase for methylation of 4-OH of the sugar in the biosynthesis of coumermycin A 1 , respectively. Cmethylation of the aminocoumarin ring is considered as an early step of coumermycin biosynthesis. Nevertheless, the intermediates with the nonmethylated aminocoumarin ring were accepted by the enzymes catalysing the subsequent steps of the pathway. The new, demethylated secondary metabolites were produced in an amount at least as high as that of coumermycin A 1 in the wild-type.
INTRODUCTION
Aminocoumarin antibiotics, such as novobiocin, clorobiocin and coumermycin A " (Berger & Batcho, 1978) , are produced by various Streptomyces strains and are very potent against Gram-positive bacteria, including methicillin-resistant Staphylococcus strains. Novobiocin is licensed in the US as an antibiotic for use in humans (Albamycin ; Pharmacia & Upjohn).
The mechanism of action of the aminocoumarin antibiotics is well studied. Bacterial DNA gyrase is their target (Hooper et al., 1982 ; Maxwell, 1999) 
Abbreviations : CID, collision-induced dissociation ; ESI, electrospray ionization.
The GenBank accession number for the sequence reported in this paper is AF235050.
crystallographic examinations demonstrated that the aminocoumarin moiety and the substituted deoxysugar moiety are essential for the binding of these compounds to the B subunit of gyrase (Ali et al., 1993 ; Lewis et al., 1996 ; Maxwell, 1993 ; Tsai et al., 1997) . The affinity of coumermycin A " for intact gyrase is extremely high : 50 % inhibition of gyrase is reportedly achieved by coumermycin A " in a concentration of only 0n004 µM, compared to 0n1 µM for novobiocin, 1n8 µM for norfloxacin and 110 µM for nalidixic acid (Peng & Marians, 1993) . Correspondingly, coumermycin A " has been found to exhibit a much higher antibacterial activity than novobiocin (Ryan, 1979) . These features make coumermycin A " a most interesting starting compound for the development of new aminocoumarin antibiotics, which may serve as anti-infective agents against multiresistant Gram-positive bacteria.
Coumermycin A "
(1, Fig. 1 ), produced by Streptomyces rishiriensis DSM 40489, contains two 3-amino-4,7-dihydroxy-8-methylcoumarin moieties, which are attached via amide bonds to a central pyrrole unit, i.e. 3-methylpyrrole 2,4-dicarboxylic acid. Two unusual 5-gem-dimethyl sugar units are linked to the 7-hydroxyl groups of the two aminocoumarin rings via glycosidic bonds. Both deoxysugars are acylated with 5-methylpyrrole-2-carboxylic acid at position 3.
In the structurally similar novobiocin, it has been shown that the aminocoumarin moiety is derived from -tyrosine, and the deoxysugar (called noviose) is formed from glucose (Bunton et al., 1963 ; Li et al., 1998) . The pyrrole moieties of coumermycin A " have been reported to be derived from -proline (Scannell & Kong, 1969) . Coumermycin A " contains at least eight methyl groups, presumably derived from S-adenosylmethionine. Feeding experiments on novobiocin biosynthesis, using "%CH $ -labelled methionine (Birch et al., 1960) and [1-"$C]glucose (Li et al., 1998) , have shown that the methyl groups at C-8 of the aminocoumarin ring, the methyl groups at the 4-OH of the deoxysugar and one of the two methyl groups at C-5 of the deoxysugar probably originated from S-adenosylmethionine. The other methyl group at C-5 of the deoxysugar is derived from C-6 of glucose after reduction. Coumermycin A " contains two further methyl groups at C-5 of the terminal pyrrole moieties. Coumermycin derivatives lacking one or both of these methyl groups were identified in the coumermycin-producing strains (Claridge et al., 1984) . It might therefore be expected that these methyl groups at the terminal pyrrole units are also derived from Sadenosylmethionine. The origin of the methyl group at C-3 of the central pyrrole unit has not been established, but this group also may be derived from S-adenosylmethionine. Therefore, at least four different methyltransferases are expected to be involved in the biosynthesis of coumermycin A " . None of the methyltransferases involved in novobiocin or coumermycin biosynthesis has been functionally identified. Our group has recently cloned and sequenced the biosynthetic gene clusters of novobiocin from Streptomyces spheroides NCIMB 11891 (Steffensky et al., 2000b) , of coumermycin A " from S. rishiriensis DSM 40489 (Wang et al., 2000) and of clorobiocin from Streptomyces roseochromogenes DS 12.976 (unpublished results). The three clusters share extensive similarities. To create a consistent nomenclature for the corresponding biosynthetic genes of these clusters, we have recently revised the nomenclature of the coumermycin biosynthetic genes (see GenBank entry AF235050). Sequence analysis of the coumermycin biosynthetic gene cluster (Wang et al., 2000) led to the identification of three putative methyltransferase genes, i.e. couU, couO and couP (formerly designated as cumW, cumM and cumN, respectively). The predicted gene product of couU, as well as that of the very similar novU of the novobiocin cluster, showed high sequence similarity to enzymes that have been functionally identified as Cmethyltransferases carrying out the C-methylation of deoxysugar during antibiotic biosynthesis. CouU, for example, shows 48 % identity to MtmC, which is responsible for the 3-C-methylation reaction in the biosynthesis of -mycarose, a deoxysugar moiety of mithramycin (Gonzalez et al., 2001 ). Likewise, CouU shows 37 % identity to TylCIII and 35 % to EryBIII, found in the biosynthetic gene clusters of tylosin and erythromycin A, respectively. Like MtmC, TylCIII and EryBIII catalyse the methylation of dTDP--mycarose at C-3 during the biosynthesis of these two antibiotics (Bate et al., 2000 ; Gaisser et al., 1998) . CouU shows also 35 % identity to AviG1, a 3-C-methyltransferase involved in the biosynthesis of the deoxysugar 2-deoxy--evalose present in the antibiotic avilamycin (Weitnauer et al., 2002) . Therefore couU was assigned to the Cmethyltransferase reaction involved in the biosynthesis of the deoxysugar noviose (Wang et al., 2000) . Recently, a new subgroup of radical S-adenosylmethionine proteins has been identified by bioinformatic techniques (Sofia et al., 2001) . The gene couN6 of the coumermycin cluster (formerly designated as cumK) shows sequence similarity to these enzymes and is therefore likely to represent a methyltransferase. Since couN6 is contained in a putative transcription unit with genes of pyrrole biosynthesis, and since no homologue for couN6 is found in the novobiocin cluster, it appears likely that couN6 may be responsible for the introduction of the methyl groups into the pyrrole moieties of coumermycin A " . In this study, we report the functional identification of two further methyltransferase genes, couO and couP, from the coumermycin A "
cluster by means of gene inactivation and the identification of the new secondary metabolites accumulated in the defective mutants.
METHODS
Bacterial strains and plasmids. S. rishiriensis DSM 40489 [DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen), Braunschweig, Germany] was routinely cultivated at 28 mC for 2 days in HA medium (Steffensky et al., 2000b) containing 1n0 % malt extract, 0n4 % yeast extract, 0n4 % glucose and 1n0 mM CaCl # (pH 7n3). Escherichia coli XL-1 Blue MRFh (Stratagene) was grown in liquid or solid Luria-Bertani medium at 37 mC (Sambrook & Russell, 2001) . pGem-3Zf(k) and pUC18 were purchased from Promega and Amersham Biosciences, respectively. pKC1132, a non-replicative vector carrying an apramycin resistance deteminant, was described by Bierman et al. (1992) . Carbenicillin (50 µg ml − ") and apramycin (50 µg ml − ") were used for selection of recombinant plasmids and strains. Genetic procedures. Standard methods for DNA isolation and manipulation were performed as described by Sambrook & Russell (2001) and Kieser et al. (2000) . DNA fragments were isolated from agarose gels using a NucleoSpin 2 in 1 extraction kit (Macherey-Nagel). Genomic DNA was isolated from Streptomyces strains by lysozyme treatment and phenol\ chloroform extraction as described elsewhere (Kieser et al., 2000) . Southern blot analysis was performed on Hybond-N membranes (Amersham Biosciences) with digoxigenin-labelled probes by using DIG high prime DNA labelling and detection kit II (Roche Molecular Biochemicals).
Construction of the vector pLW3 for in-frame gene inactivation of couO. A SphI-PstI fragment of 3n89 kb containing genes couN6, couN7, couO and couP was isolated from cosmid 4-2H (Wang et al., 2000) and cloned into the same sites of pGem-3Zf(k), resulting in vector pLW1. Vector pLW2, containing a deletion of 366 bp within couO, was constructed by ligation of two restriction fragments of pLW1, i.e. a 5n09 kb EcoRI-SfoI fragment and a 0n98 kb SmaI-EcoRI fragment. pLW3 was obtained by cloning of a 3n52 kb HindIII-PstI fragment from pLW2 into the same sites of vector pKC1132 (Fig. 2a) .
Construction of the vector pLW9 for in-frame gene inactivation of couP. A NarI fragment of 3n08 kb containing couO, couP and couR1 was isolated from cosmid 4-2H and cloned into the AccI sites of pUC18 to give vector pLW7. pLW7 was restricted with BclI, and the 5n09 kb fragment was religated, resulting in a deletion of 678 bp within the couP gene. The vector obtained was termed pLW8. The 2n56 kb XbaI-HindIII fragment was released from pLW8 and ligated into the same sites of pKC1132, resulting in the inactivation vector for couP, pLW9 (Fig. 3a) .
Transformation of S. rishiriensis and selection for recombinant mutants. Transformation of the S. rishiriensis wild-type with pLW3 and pLW9 was carried out by polyethylene glycol-mediated protoplast transformation (Kieser et al., 2000) . For preparation of protoplasts, mycelia of S.
rishiriensis were grown in CRM medium, containing 10n3% sucrose, 2n0 % tryptic soy broth, 1n0 % MgCl # .6H # O, 1n0% yeast extract and 0n4 % glycine (pH 7n0), for 42-48 h, harvested, and incubated in 4 ml P-buffer per g mycelia, containing 0n3 mg lysozyme (Sigma) ml − ", for 30-60 min at 30 mC. For transformation, pLW3 and pLW9 were isolated from E. coli ET 12567 (MacNeil et al., 1992) using ion-exchange columns (Nucleobond AX kits ; Macherey-Nagel), according to the manufacturer's protocol, and denaturated by alkaline treatment (Oh & Chater, 1997) . The resulting single-stranded DNA (10 µg in 10 µl TE-buffer) was mixed with 200 µl P-buffer containing 10) S. rishiriensis protoplasts and 500 µl T-buffer containing 25 % (w\v) polyethylene glycol 1000 (Roth) (Kieser et al., 2000) . The resulting suspension was plated on three R2YE agar plates (Kieser et al., 2000) . After incubation for 20 h at 30 mC, each plate was overlaid with 3 ml soft R2YE agar containing a total of 500 µg apramycin, for selection of recombinant mutants. Apramycin-resistant, single-crossover mutants were cultured in liquid HA medium without antibiotics and sporulated after four subcultures on solid HA medium without antibiotics. The spores were tested for loss of apramycin resistance by culturing the colonies on HA plates with and without apramycin. Sensitive colonies were subjected to Southern blotting. Production and analysis of secondary metabolites. For the production of coumermycin derivatives, wild-type and mutant strains of S. rishiriensis were pre-cultured in 300 ml baffled flasks containing 50 ml HA medium. After growth for 48 h at 28 mC and 180 r.p.m., 3 ml of this pre-culture was inoculated into 500 ml baffled flasks containing 100 ml production medium (Scannell & Kong 1969) . In this medium, cells were cultured at 28 mC and 180 r.p.m. for 7 days. Aliquots (6 ml) of the cultures were then extracted with 2i6 ml ethyl acetate after treatment with 2i6 ml petroleum ether to remove lipophilic substances. After evaporation of the solvent, the residue was dissolved in 0n6 ml ethanol and analysed on a Hewlett Packard HPLC system with a photo diode-array detector. The analysis was performed with a Nucleosil 120-5 C18 column (2i250 mm ; Macherey-Nagel) and a linear gradient from 30 to 100 % acetonitrile in 0n1% aqueous phosphoric acid. Detection was at 345 nm. HPLC-MS and selected reaction monitoring. The positive and negative electrospray ionization (ESI) mass spectra were obtained from a Finnigan MAT TSQ 7000 instrument (electrospray voltage, 4n5 kV ; heated capillary temperature, 220 mC ; sheath and auxiliary gas, nitrogen) coupled with a Micro-Tech Ultra-Plus MicroLC system equipped with an RP18 column (5 µm, 1i100 mm ; SepServ). For all samples, a gradient system ranging from 80 : 20 H # O\CH $ CN (each of them containing 0n2 % HOAc) to 10 : 90 over 15 min, followed by isocratic elution with a 10 : 90 mixture of both solvents for 25 min, was used ; the flow rate was 70 µl min − ". The collisioninduced dissociation (CID) spectra of coumermycin A " and the selected reaction monitoring during an HPLC run were recorded with a collision energy of k25 eV for positive ions and j40 eV for negative ions, respectively ; collision gas, argon ; collision pressure, 1n8i10 − $ torr (240i10 − $ Pa). The positive-ion ESI-CID mass spectrum of coumermycin A " Assay for antibacterial activity. The antibacterial activities of coumermycin derivatives were tested using Bacillus subtilis ATCC 14893. Cultures of S. rishiriensis (wild-type and mutant strains) were cultured and extracted as described for HPLC analysis. For the bioassays, 30 µl of an ethanolic solution of the ethyl acetate extracts was applied to filter-paper discs (5 mm diameter) and air-dried for 30 min. The discs were then placed on Difco nutrient agar plates (Kieser et al., 2000) containing approximately 2i10& spores of B. subtilis per ml agar medium. After culture overnight at 37 mC, the diameter of the growth-inhibition zone was determined.
RESULTS

Sequence analysis of couO and couP
Two adjacent ORFs, couO and couP, encoding putative methyltransferases were found in the coumermycin A " biosynthetic gene cluster (Wang et al., 2000) . Two very similar genes, novO and novP, are found in the novobiocin biosynthetic cluster. The functions of these genes have not been established. The predicted gene product of couO comprises 230 amino acids and shows only low sequence similarity to putative methyltransferases in the database, e.g. 29 % identity (at amino acid level) to the C-methyltransferase UbiE (GenBank accession no. AE010901) of the ubiquinone\menaquinone biosynthesis in Methanosarcina acetivorans (Galagan et al., 2002) 
. Conserved motif III [LL(R\K)PGG(R\I\L)(L\I)(L\F\I\V)(I\L)] for S-adenosylmethionine-dependent methyltransferases (Kagan & Clarke 1994) is found from amino acid 135 to 144 of CouO (LVKPGGAILN). In the biosynthesis of coumermycin A "
, C-methyltransferases may be involved in the methylation of C-8 of the aminocoumarin ring, of C-5 of the terminal pyrrole, and possibly of C-3 of the central pyrrole unit, besides the C-methylation reaction at C-5 of the deoxysugar. The predicted gene product of couP consists of 276 amino acids. In contrast to CouO, CouP shows high similarities to known deoxysugar O-methyltransferases in the database, e.g. 57 % identity to 3-O-methyltransferase MycF catalysing the methylation at the 3-position of the deoxysugar mycinose of mycinamicin III (Inouye et al., 1994) , 59 % to ElmMIII responsible for 4-O-methylation of the permethylated -rhamnose in the biosynthesis of elloramycin A (Patallo et al., 2001) , and 53 % to 3-O-methyltransferase TylF converting macrocin to tylosin by O-methylation at C-3 of the deoxysugar mycinose (Fouces et al., 1999) (Kagan & Clarke, 1994) was found in the predicted CouP from amino acid 105 to 113 (LVETGVWRG).
. Conserved motif I [(V\I\L)(L\V)(D\E)(V\I)G(G\C)G(T\P)G] for S-adenosylmethionine-dependent methyltransferases
Construction of the inactivation vectors
To provide experimental evidence for the functions of couO and couP, inactivation vectors were prepared for both genes. A vector containing an in-frame deletion within the coding sequence of couO was obtained by the cloning of a SphI-SfoI fragment of 1926 bp and a SmaI-EcoRI fragment of 983 bp from a cosmid containing the coumermycin cluster into the non-replicative vector pKC1132 (containing an apramycin resistance determinant), via the cloning vector pGem-3Zf(k). The resulting inactivation vector was termed pLW3 (Fig. 2a) . The predicted product of couO is thereby expected to be shortened from 230 (wild-type) to 108 (mutants) amino acids. The inactivation vector for couP (pLW9) (Fig. 3a) contained an in-frame deletion within the structural gene of couP. This could be achieved by excision of a 678 bp BclI fragment from a subclone of the coumermycin gene cluster, and ligation of the resulting fragment into pKC1132. The predicted product of the shortened couP consists of only 50 amino acids, in comparison to 276 amino acids in the wild-type.
Transformation of S. rishiriensis with pLW3, and selection of couO-defective mutants
Vector pLW3 was transformed into S. rishiriensis protoplasts (Kieser et al., 2000 ; Wang et al., 2000) , and apramycin-resistant colonies were selected. Southern blotting confirmed that pLW3 had been integrated into these mutants via a single-crossover recombination event (Fig. 2b) . One of these single-crossover mutants (LW-O11) was grown in the absence of apramycin, sporulated, and examined for loss of resistance as a consequence of double-crossover events. Four sensitive colonies, LW-O41, LW-O61, LW-O316 and LW-O318, were obtained and examined further. Chromosomal DNA from these four strains and from the S. rishiriensis wild-type was digested with BamHI and hybridized with a probe containing the complete sequence of the couO gene. A band at 1n43 kb, corresponding to the intact couO, was detected in the S. rishiriensis wild-type, while chromosomal DNA from mutants LW-O41 and LW-O316 showed a band at 1n07 kb, corresponding to the inactivated couO (Fig. 2b) . The other two sensitive strains, LW-O61 and LW-O318, showed a band of the same size as the wild-type (1n43 kb) and therefore represented reversion to the wild-type.
Transformation of S. rishiriensis with pLW9, and selection of couP-defective mutants
The introduction of vector pLW9 into the S. rishiriensis genome and the selection of double-crossover mutants were carried out as described above for pLW3. This procedure yielded the single-crossover mutant LW-P10 and, subsequently, the antibiotic-sensitive, double-crossover mutants LW-P582 and LW-P634. Southern blotting with chromosomal DNA, restricted with HincII and hybridized with a 1n1 kb PstI-HincII fragment containing the region just downstream of couP as probe, showed that LW-P634 was the desired couP mutant, showing a band at 1n72 kb. LW-P582 represented a reversion to the wild-type, with a band at 2n40 kb, as for the wild-type (Fig. 3b) .
Identification of secondary metabolites in the defective mutants
S. rishiriensis wild-type, the couO mutants (LW-O41 and LW-O316) and the couP mutant (LW-P634) were cultured under the conditions described by Scannell & Kong (1969) . After extraction of the cultures with ethyl acetate, secondary metabolites were analysed by HPLC. As shown in Fig. 4 , the production of coumermycin A " was abolished in all mutants. The HPLC chromatogram of strain LW-O316 was identical to that of LW-O41 (data not shown). Instead, the couO mutant LW-O41 showed a dominant peak at 19n7 min (2) and the couP mutant showed a dominant peak at 17n5 min (3). The two peaks 2 and 3 showed UV spectra similar to that for coumermycin A " with two maxima at 275 and 345 nm (data not shown). HPLC-MS showed both substances to have identical molecular ions : m\z at 1082 [MjH] + in the positive mode and m\z at 1080 [MkH] − in the negative mode. Therefore substances 2 and 3 have a molecular mass of 1081, corresponding to a loss of two methyl groups relative to coumermycin A " (M r 1109).
To determine the positions of the remaining methyl groups in 2 and 3, we employed MS using selected reaction monitoring via ESI during positive and negative ionization. Fragmentation of coumermycin A " occurred at the amide, the glycosidic and the ester bonds, producing ions at m\z 487 (ESIk), m\z 282 (ESIj) and m\z 108 (ESIj), respectively (Fig. 5a ). In addition, the ion at m\z 206 (ESIk), representing the methylated aminocoumarin ring (4), was observed. Fig. 5 (Fig. 5) . This proved that the couO mutant produced a new coumermycin, lacking the 8-methyl groups at both aminocoumarin rings (Fig. 5, 2) . This new coumermycin was designated coumermycin LW1.
In compound 3 produced by the couP mutant, selected reaction monitoring showed the reaction confirming the presence of the methylated aminocoumarin moiety 4. However, instead of the m\z 1082 m\z 282 reaction, a reaction of m\z 1082 ([MjH] + ) m\z 268 was now observed, indicating the loss of a methyl group from either the deoxysugar or the terminal pyrrole unit. However, since the fragment at m\z 108 (ESIj) was still observed, it is obvious that the pyrrole moiety is unchanged in comparison to coumermycin A "
, and that therefore a methyl group is lacking from the deoxysugar in comparison to coumermycin A " .
The S. rishiriensis wild-type produced about 5 mg coumermycin A " per litre medium under the culture conditions described. Judging from the peak areas in the HPLC chromatograms, the couO and couP mutants produced at least as much of the new metabolites, i.e. coumermycin LW1 and LW2, respectively (Fig. 4) .
Antibiotic activity of culture extracts from the couO and the couP mutants Cultures of S. rishiriensis wild-type as well as of the couO and the couP mutants were extracted with ethyl acetate and assayed (against B. subtilis) for antibiotic activity (Fig. 6 ). All three strains showed similar antibacterial activity, indicating that neither the methyl group at C-8 of the aminocoumarin ring nor the methyl group at 4-OH of the deoxysugar was essential for the antibiotic activity of the coumermycins.
DISCUSSION
In the present study, we have inactivated the putative methyltransferase genes couO and couP by in-frame deletion, and have identified the products formed in the resulting mutants by HPLC-MS analysis, using selected reaction monitoring for structure elucidation.
Inactivation of couO led to a new product (coumermycin LW1) which lacked the methyl groups of the aminocoumarin moieties. This provides strong evidence that couO encodes the C-methyltransferase responsible for the methylation of C-8 of these aminocoumarin rings. However, it is still unclear at which stage of coumermycin biosynthesis (or correspondingly of novobiocin biosynthesis) this reaction occurs. The aminocoumarin ring is derived from tyrosine, and the methylation reaction may take place prior to, during, or after the conversion of -tyrosine to 3-amino-4,7-dihydroxycoumarin (Chen & Walsh, 2001 ). We have previously inactivated an early step of deoxysugar biosynthesis in novobiocin formation, and the mutant accumulated large amounts of novobiocic acid, the aglycone of novobiocin (Steffensky et al., 2000b) . This indicates that methylation of C-8 takes place prior to glycosylation, and probably before acylation of the amino group of the aminocoumarin (Steffensky et al., 2000a) . Nevertheless, the unmethylated aminocoumarin produced by the couO mutant was accepted as substrate by all subsequent enzymes of coumermycin biosynthesis (Fig. 1) , and the resulting product, coumermycin LW1, was accumulated in an amount at least as high as that of coumermycin A " in the wild-type. This proves that there is no strict substrate specificity for the substituent in this position of the aminocoumarin. This is also indicated by the natural occurrence of novobiocin analogues lacking the 8-methyl group, as recently reported by Sasaki et al. (2001) , and by the simultaneous occurrence of simocyclinones with and without a substituent at the corresponding position of the aminocoumarin ring (Theobald et al., 2000) .
Inactivation of another methyltransferase gene, couP, in the present study also led to the formation of a new coumermycin (termed coumermycin LW2) lacking two methyl groups. Mass spectroscopic analysis with selected reaction monitoring proved that these methyl groups were lacking from the deoxysugar moiety. Since Cmethylation at C-5 had been assigned to couU, this result suggests that couP encodes a methyltransferase responsible for the methylation of the 4-hydroxyl groups of the deoxysugar moieties of coumermycin. This is also in accordance with the sequence similarity of couP to known deoxysugar O-methyltransferases (see Results).
In novobiocin biosynthesis, acylation of 3-OH and methylation of 4-OH of the deoxysugar moiety have been suggested as the two final steps of the biosynthetic 6 . Antibacterial activity of culture extracts from S. rishiriensis wild-type (1), the couO-defective mutant (2) and the couP-defective mutant (3). Extracts from non-inoculated culture medium (4) and a coumermycin A 1 standard (5) were used for comparison. Antibiotic activity against B. subtilis was determined as described in Methods.
pathway, since novobiocin derivatives lacking either or both substituent(s) have been identified in mutants of the novobiocin producer Streptomyces niveus (Kominek & Sebek, 1974) . At first sight, the very high accumulation of coumermycin LW2 in the couP mutant may appear to indicate that 4-O-methylation is the last step of coumermycin A " biosynthesis. In the study by Kominek & Sebek (1974) mentioned above, however, it was shown by mutation and biotransformation experiments that 4-O-methylation of the deoxysugar could be achieved before or after acylation of the 3-hydroxyl group. It has been shown repeatedly that several enzymes of coumarin antibiotic biosynthesis are not strictly substrate specific. The flexibility for the substituent at the position 8 of the aminocoumarin discussed above provides one example. Another is the occurrence of a novobiocin derivative lacking one of the 5-methyl groups of noviose, detected as a side-product from a novobiocin producer (Sasaki et al., 2001) . Therefore, the exact sequence of the biosynthetic reactions depicted in Fig. 1 remains tentative. The flexibility of the enzymes of coumarin antibiotic biosynthesis for different substrates presents a very useful feature in experiments for the production of new antibiotics by combinatorial biosynthesis (Tang & McDaniel, 2001 ; Yoon et al., 2002) , and this study has provided two examples of the production of new antibiotics by genetic methods.
